Nabholtz JM - Search Results

1

Use of PEG-rHuMGDF in platelet engraftment after autologous stem cell transplantation.

Fields KK, Crump M, Bence-Bruckler I, Bernstein S, Williams S, Frankel S, Miller A, Demetri G, Nabholtz JM, Cruickshank S, Lill M. Fields KK, et al. Among authors: nabholtz jm. Bone Marrow Transplant. 2000 Nov;26(10):1083-8. doi: 10.1038/sj.bmt.1702662. Bone Marrow Transplant. 2000. PMID: 11108307 Clinical Trial.

2

Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature.

Mackey JR, Desai S, Larratt L, Cwik V, Nabholtz JM. Mackey JR, et al. Among authors: nabholtz jm. Bone Marrow Transplant. 1997 May;19(9):939-42. doi: 10.1038/sj.bmt.1700759. Bone Marrow Transplant. 1997. PMID: 9156270

3

Docetaxel/doxorubicin/cyclophosphamide in the treatment of metastatic breast cancer.

Nabholtz JM, Smylie M, Mackey J, Paterson A, Noel D, al-Tweigeri, Janowska A, Delorme F, Riva A. Nabholtz JM, et al. Oncology (Williston Park). 1997 Jun;11(6 Suppl 6):25-7. Oncology (Williston Park). 1997. PMID: 9213324 Clinical Trial.

4

Liarozole fumarate (R85246): a novel imidazole in the treatment of receptor positive postmenopausal metastatic breast cancer.

Goss PE, Oza A, Goel R, Nabholtz JM, De Coster R, Bruynseels J, Reid C, Wadden N, Crump M, Tye LM. Goss PE, et al. Among authors: nabholtz jm. Breast Cancer Res Treat. 2000 Jan;59(1):55-68. doi: 10.1023/a:1006320122711. Breast Cancer Res Treat. 2000. PMID: 10752680 Clinical Trial.

5

Liarozole fumarate (R85246): in the treatment of ER negative, tamoxifen refractory or chemotherapy resistant postmenopausal metastatic breast cancer.

Goss PE, Strasser K, Marques R, Clemons M, Oza A, Goel R, Blackstein M, Kaizer L, Sterns EE, Nabholtz JM, De Coster R, Crump M, Abdolell M, Qi S. Goss PE, et al. Among authors: nabholtz jm. Breast Cancer Res Treat. 2000 Nov;64(2):177-88. doi: 10.1023/a:1006480504790. Breast Cancer Res Treat. 2000. PMID: 11194453 Clinical Trial.

6

Endogenous Erythropoietin, Tumor Necrosis Factor-α and Interleukin-6 Levels after Peripheral Blood Stem Cell Transplantation.

Matsuzaki A, Nabholtz JM, Nahirniak S, Janowska-Wieczorek A. Matsuzaki A, et al. Among authors: nabholtz jm. Hematology. 1997;2(2):151-9. doi: 10.1080/10245332.1997.11746331. Hematology. 1997. PMID: 27406806 Free article.

7

Docetaxel (Taxotere) in combination with anthracyclines in the treatment of breast cancer.

Nabholtz JM, North S, Smylie M, Mackey J, Au HJ, Au R, Morrish D, Salter E, Tonkin K. Nabholtz JM, et al. Semin Oncol. 2000 Apr;27(2 Suppl 3):11-8. Semin Oncol. 2000. PMID: 10810933 Review.

8

Review of docetaxel and doxorubicin-based combinations in the management of breast cancer: from metastatic to adjuvant setting.

Nabholtz JM, Tonkin K, Smylie M, Mackey J, Janowska-Wieczorek A. Nabholtz JM, et al. Semin Oncol. 1999 Feb;26(1 Suppl 3):10-6. Semin Oncol. 1999. PMID: 10203265 Review.

9

Docetaxel and anthracycline polychemotherapy in the treatment of breast cancer.

Nabholtz JM, Smylie M, Mackey J, Au HJ, Tonkin K, Au R, Morrish D, Salter E. Nabholtz JM, et al. Semin Oncol. 1999 Jun;26(3 Suppl 8):47-52. Semin Oncol. 1999. PMID: 10403474 Review.

10

Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?

Nabholtz JM, Tonkin K, Smylie M, Au HJ, Lindsay MA, Mackey J. Nabholtz JM, et al. Expert Opin Pharmacother. 2000 Jan;1(2):187-206. doi: 10.1517/14656566.1.2.187. Expert Opin Pharmacother. 2000. PMID: 11249542 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

112 results

Search Page

Filters